Sinopharm Group Co. Ltd. (SHTDY)

AI Score

Unlock

11.10

0.26 (2.40%)

At close: Apr 25, 2025, 3:58 PM

Sinopharm Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	147.46B	147.27B	150.65B	144.97B	155.43B	145.52B	145.77B	144.91B	133.87B	127.6B	139.77B	132.17B	128.85B	120.27B	128.8B	123.85B	109.37B	94.4B	112.58B	111.02B	106.49B	95.18B	93.71B	87.35B	84.53B	78.94B	85.29B	85.29B	68.88B	68.88B	65.79B	65.79B	64.22B	62.58B
Cost of Revenue	136.09B	136.69B	137.33B	133.04B	143.1B	134.58B	132.38B	132.52B	122.23B	117.59B	128.19B	120.28B	117.49B	111.05B	117.24B	112.33B	99.42B	87.1B	102.28B	101.28B	96.69B	87.49B	85.06B	79.23B	76.51B	72.5B	77.71B	77.71B	63.44B	63.44B	60.6B	60.6B	58.99B	57.53B
Gross Profit	11.37B	10.58B	13.31B	11.93B	12.33B	10.94B	13.39B	12.39B	11.65B	10.01B	11.58B	11.88B	11.37B	9.22B	11.56B	11.52B	9.95B	7.3B	10.31B	9.74B	9.8B	7.68B	8.65B	8.12B	8.02B	6.45B	7.58B	7.58B	5.45B	5.45B	5.2B	5.2B	5.23B	5.05B
Operating Income	5.13B	3.39B	7.76B	3.46B	5.82B	4.01B	8.02B	3.53B	5.75B	3.76B	6.67B	5.24B	5.86B	3.21B	6.11B	5.41B	5.03B	2.55B	5.48B	4.38B	5.15B	3.16B	4.64B	3.58B	4.54B	2.64B	3.62B	3.62B	2.94B	2.94B	2.49B	2.49B	2.77B	2.45B
Interest Income	n/a	277.38M	345M	n/a	922.32M	382.36M	330.33M	786.82M	845.56M	633.06M	1.05B	628.82M	1.02B	456.63M	714.38M	658.61M	792.03M	539.13M	642.5M	882.52M	679.93M	667.59M	240.22M	589.67M	1.04B	667.67M	767.34M	767.34M	433.96M	433.96M	461.17M	461.17M	427.38M	374.04M
Pretax Income	4.47B	3.12B	6.49B	4.16B	5.23B	3.64B	5.97B	4.59B	4.85B	3.15B	4.76B	4.52B	4.93B	2.79B	4.87B	4.51B	4.24B	1.97B	3.94B	3.43B	3.89B	2.5B	3.71B	2.86B	3.68B	1.97B	3.03B	3.03B	2.58B	2.58B	2.03B	2.03B	2.83B	2.03B
Net Income	2.28B	1.42B	2.96B	1.99B	2.51B	1.59B	2.67B	2.16B	2.27B	1.43B	2.06B	2.12B	2.37B	1.22B	2.23B	2.06B	2.08B	812.02M	1.66B	1.62B	1.83B	1.14B	1.72B	1.32B	1.9B	891.56M	1.41B	1.41B	1.38B	1.38B	1.05B	1.05B	1.52B	1.02B
Selling & General & Admin	6.87B	6.84B	7.06B	5.73B	7.05B	6.64B	7.81B	5.66B	6.39B	5.99B	6.16B	5.73B	6B	5.76B	6.56B	5.34B	5.29B	4.69B	5.82B	4.63B	5B	4.34B	4.88B	3.9B	3.78B	3.68B	4.06B	4.06B	2.61B	2.61B	2.8B	2.8B	2.65B	2.48B
Research & Development	71.13M	71.13M	260.77M	260.77M	95.96M	95.96M	210.37M	210.37M	61.62M	61.62M	126.04M	126.04M	42.25M	42.25M	97.24M	97.24M	27.66M	27.66M	96.78M	96.78M	32.84M	32.84M	74.65M	74.65M	22.12M	22.12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-702.85M	566.23M	n/a	9.36M	n/a	n/a	28.31M	-7.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.24B	7.18B	6.48B	417.63B	6.18B	6.92B	-366.01B	379.04B	5.95B	6.23B	5.77B	6.73B	5.42B	5.97B	5.98B	6.35B	4.91B	4.78B	5.72B	5.43B	5.23B	4.52B	4.7B	4.67B	3.3B	3.81B	3.78B	3.78B	2.43B	2.43B	2.71B	2.71B	1.97B	2.65B
Interest Expense	n/a	n/a	n/a	512.59M	n/a	n/a	1.27B	449.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	4.27B	4.21B	4.82B	4.21B	4.3B	4.13B	4.8B	4.14B	3.98B	3.8B	3.77B	4.06B	3.85B	3.75B	4.29B	3.59B	3.26B	3B	3.62B	3.1B	3.05B	2.79B	2.96B	2.66B	2.43B	2.32B	2.53B	2.53B	1.66B	1.66B	1.74B	1.74B	1.59B	1.56B
Cost & Expenses	142.33B	143.87B	143.82B	139.95B	149.28B	141.5B	138.7B	139.22B	128.17B	123.82B	133.95B	127.01B	122.91B	117.02B	123.22B	118.67B	104.33B	91.89B	108B	106.71B	101.92B	92.01B	89.76B	83.9B	79.81B	76.31B	81.49B	81.49B	65.87B	65.87B	63.3B	63.3B	60.96B	60.18B
Income Tax Expense	972.43M	724.85M	1.54B	987.09M	1.14B	827.84M	1.44B	1B	1.05B	721.61M	1.21B	1.04B	1.06B	629.22M	1.06B	1.02B	870.76M	543M	932.33M	789.31M	835.39M	582.71M	886.64M	666.63M	795.47M	454.71M	718.18M	718.18M	562.73M	562.73M	463.38M	463.38M	632.91M	473.56M
Shares Outstanding (Basic)	624.13M	623.6M	623.6M	623.6M	623.06M	623.66M	629.14M	622.5M	625.91M	620.82M	627.27M	622.73M	624.6M	623.67M	696.85M	552.26M	619.37M	624.63M	602.48M	591.75M	601.87M	587.17M	723.18M	471.86M	631.85M	557.22M	634.02M	634.02M	552.27M	552.27M	552.55M	552.55M	555.61M	551.22M
Shares Outstanding (Diluted)	624.13M	623.6M	623.6M	623.6M	623.06M	623.66M	629.14M	622.5M	625.91M	620.82M	627.27M	620.99M	624.6M	623.67M	696.81M	552.26M	616.1M	624.63M	598.52M	591.75M	601.49M	587.17M	719.34M	471.86M	631.44M	557.22M	635.24M	635.24M	553.42M	553.42M	553.42M	553.42M	555.61M	551.22M
EPS (Basic)	3.65	2.30	4.70	3.20	4.05	2.55	4.25	3.45	3.60	2.30	3.30	3.40	3.80	1.95	3.20	3.75	3.35	1.30	2.75	2.75	3.05	1.95	2.35	2.80	3.00	1.60	2.20	2.20	2.50	2.50	1.90	1.90	2.75	1.85
EPS (Diluted)	3.65	2.30	4.70	3.20	4.05	2.55	4.25	3.45	3.60	2.30	3.30	3.40	3.80	1.95	3.20	3.75	3.40	1.30	2.75	2.75	3.05	1.95	2.40	2.80	3.00	1.60	2.20	2.20	2.50	2.50	1.90	1.90	2.75	1.85
EBITDA	5.57B	3.91B	8.29B	4.53B	6.36B	4.52B	8.49B	5.04B	6.27B	4.24B	7.15B	5.68B	6.35B	3.66B	6.56B	5.84B	5.44B	2.98B	5.91B	4.7B	5.51B	3.48B	4.96B	3.87B	4.87B	2.93B	3.95B	3.95B	3.18B	3.18B	2.72B	2.72B	3.02B	2.68B
EBIT	4.99B	3.39B	7.76B	4.53B	5.82B	4.01B	7.24B	5.04B	5.75B	3.76B	6.67B	5.24B	5.86B	3.21B	6.11B	5.41B	5.03B	2.55B	5.48B	4.38B	5.15B	3.16B	4.64B	3.58B	4.54B	2.64B	3.62B	3.62B	2.94B	2.94B	2.49B	2.49B	2.77B	2.45B
Depreciation & Amortization	574.76M	521.26M	521.26M	503.1M	537.12M	503.1M	503.1M	477.98M	520.16M	477.98M	477.98M	445M	492.35M	445M	445M	429.1M	407.83M	429.1M	429.1M	318.83M	363.36M	318.83M	318.83M	285.65M	327.38M	285.65M	331.26M	331.26M	240.05M	240.05M	224.99M	224.99M	257.18M	228.81M